Lecture 20 - Pharmacokinetics: Drug Interactions and Adverse Drug Reactions

Definition and Core Concepts of Drug Interactions

• Drug Interaction Definition: A drug interaction occurs when the response to a medication is modified by another external or internal factor. This modification can influence the safety, efficacy, and physiological impact of the treatment.

• Influencing Factors: The factors that can modify a drug response include:

  • Other drugs (Drug-Drug Interaction).

  • Food and beverages (Food-Drug Interaction).

  • Dietary supplements.

  • Underlying disease conditions (Drug-Disease Interaction).

  • Formulation ingredients.

  • Environmental agents, such as smoking or alcohol consumption.

• General Outcomes: Interactions can result in several consequences:

  • Increased toxicity.

  • Reduced therapeutic effect (treatment failure).

  • Enhanced beneficial effects (synergy utilized clinically).

Consequences and Clinical Manifestations of Drug Interactions

• Loss of Therapeutic Effect:

  • Occurs when an interaction causes drug concentrations to drop below the minimum effective level or blocks the drug's action.

  • Example: An enzyme inducer speeds up the metabolism of an oral contraceptive or an anticoagulant, potentially leading to unintended pregnancy or life-threatening blood clots.

• Disease Progression:

  • In chronic illnesses like hypertension or various infections, a reduction in drug efficacy allows the underlying condition to advance unchecked.

• Toxicity and Adverse Reactions:

  • Occurs when an interaction slows the clearance of a drug, leading to accumulation in the bloodstream at dangerous levels.

  • Intensification of side effects: Manifests as extreme drowsiness, severe nausea, or dizziness.

  • Organ Damage: Specific risks include hepatotoxicity (liver damage) or nephrotoxicity (kidney damage).

  • Critical Events: Severe interactions can cause acute medical crises, such as respiratory depression, cardiac arrhythmias, or internal bleeding.

• Altered Physiological Responses:

  • Synergistic Effects: Two drugs with similar actions combine to create a dangerous level of effect. Example: Combining an opioid with a benzodiazepine leads to extreme sedation and suppressed breathing.

  • Antagonistic Effects: Two drugs cancel out each other's effects. Example: An antihypertensive drug combined with an NSAID; the NSAID causes fluid retention and raises blood pressure, opposing the blood-pressure-lowering effect of the antihypertensive medication.

Pharmacokinetic Drug Interactions: Absorption and Distribution

• Definition: Pharmacokinetic interactions occur when one drug changes the concentration of another by affecting its Absorption, Distribution, Metabolism, or Excretion (ADME).

• Absorption Interactions: These occur when a drug interferes with another drug's entry into the bloodstream from the gastrointestinal (GI) tract.

  • Complexation and Chelation: Drugs bind with metal ions such as Calcium ($Ca^{2+}$), Magnesium ($Mg^{2+}$), Aluminum ($Al^{3+}$), or Iron ($Fe^{2+}$) to form insoluble complexes. Example: Antacids plus Tetracycline form an insoluble complex that significantly reduces absorption.

  • Changes in Gastric pH: Some drugs (e.g., Ketoconazole) require an acidic environment for dissolution. Drugs like Proton Pump Inhibitors (PPIs) or antacids increase gastric pH, causing dissolution failure and decreased efficacy.

  • Altered GI Motility: Anticholinergic drugs slow gastric emptying and intestinal motility. This delays the movement of drugs like Acetaminophen, leading to a slower onset of action.

  • Drug Transport Proteins (P-glycoprotein/PGP): PGP acts as an efflux pump, moving drugs out of cells.

    • PGP Induction: Rifampicin induces PGP, increasing the efflux of Digoxin (a substrate) from intestinal cells back into the gut, reducing bioavailability.

    • PGP Inhibition: Verapamil inhibits PGP, which allows more Digoxin to remain in the body, potentially causing toxicity.

  • Induced Malabsorption: Drugs like Neomycin can damage the intestinal mucosa, impairing the absorptive surface and reducing the absorption of drugs like Digoxin and Methotrexate.

• Distribution Interactions:

  • Primarily involves competition for plasma protein binding, specifically with Albumin.

  • Only the "free" (unbound) drug is pharmacologically active.

  • Example: NSAIDs have a high affinity for Albumin and can displace Warfarin from binding sites. This increases the free concentration of active Warfarin in the plasma, raising the risk of bleeding.

Pharmacokinetic Drug Interactions: Metabolism (CYP450 System)

• Role of Cytochrome P450 (CYP): These enzymes, primarily in the liver, are responsible for Phase $1$ metabolism. Changes in their activity directly affect drug clearance and oral bioavailability.

• Enzyme Inhibition:

  • Decreases enzyme activity, slowing drug metabolism and increasing plasma concentrations.

  • Harmful Example: Clarithromycin (a CYP3A4 inhibitor) plus Simvastatin (a substrate). Inhibited metabolism leads to Simvastatin accumulation and increased risk of muscle toxicity or rhabdomyolysis.

  • Beneficial Example: Ritonavir is a strong CYP3A4 inhibitor used clinically to "boost" the concentrations of other HIV protease inhibitors when prescribed together.

• Enzyme Induction:

  • Increases enzyme activity, accelerating metabolism and reducing therapeutic effects.

  • Example: Carbamazepine induces CYP3A4. If taken with oral contraceptives (metabolized by CYP3A4), hormone levels fall below therapeutic thresholds, increasing the risk of unintended pregnancy.

• Prodrug Activation Interactions:

  • Prodrugs are inactive and require metabolic conversion to an active form via enzymes like CYP450.

  • Example: Tamoxifen (for breast cancer) is converted to its active form, Endoxifen, by CYP2D6. If a patient takes Paroxetine (a strong CYP2D6 inhibitor), the conversion is blocked, leading to reduced efficacy or treatment failure.

Pharmacokinetic Drug Interactions: Renal Excretion

• Renal Blood Flow and GFR:

  • Glomerular Filtration Rate (GFR) depends on prostaglandins to keep renal arteries dilated. NSAIDs inhibit prostaglandin synthesis, causing renal vasoconstriction and reduced GFR.

  • Example: NSAIDs reduce the clearance of Lithium, leading to accumulation and toxicity.

• Active Tubular Secretion Competition:

  • Occurs in the proximal tubule when two drugs share the same carrier protein. The drug with higher affinity is transported, while the other accumulates.

  • Beneficial Example: Probenecid inhibits the secretion of Penicillin, allowing the antibiotic to stay in the blood longer to improve efficacy.

  • Toxic Example: NSAIDs compete with Methotrexate for secretion, leading to elevated Methotrexate levels and serious toxicity.

• Urinary pH Alteration:

  • Based on the Henderson-Hasselbalch principle: Only the unionized form of a drug can be passively reabsorbed into the blood.

  • pH Trapping: Altering the urine pH can trap a drug in its ionized form, preventing reabsorption and enhancing excretion.

  • Clinical Example: Using Sodium Bicarbonate in Aspirin overdose. It alkalinizes the urine, increasing the ionization of salicylic acid, thereby enhancing its excretion and reducing toxicity.

Pharmacodynamic Interactions

• Definition: These occur when drugs influence each other at the receptor or physiological system level without changing plasma concentrations.

• Antagonism: Drugs with opposite actions reduce each other's effects. Example: Acetylcholine decreases heart rate while Noradrenaline increases it.

• Additive/Summation Effects: The overall effect equals the sum of individual effects ($1 + 1 = 2$). Example: Combining two CNS depressants like sedatives and hypnotics leads to enhanced depression of the central nervous system.

• Synergism/Potentiation: One drug enhances the effect of another beyond what is expected (1 + 1 > 2). Example: Alcohol can enhance the analgesic activity of Aspirin.

Food-Drug and Environmental Interactions

• Grapefruit Juice: A potent CYP3A4 inhibitor. Patients taking CYP3A4 substrates like Statins (Simvastatin) or certain Calcium Channel Blockers are advised to avoid it to prevent drug accumulation.

• Dairy Products: Rich in Calcium and divalent cations. They can bind to drugs like Tetracycline or Fluoroquinolones (e.g., Ciprofloxacin), forming insoluble complexes. Patients are advised a $2$ to $4$ hour gap between dairy and medication.

• Vitamin K-Rich Foods: Foods like spinach, kale, and broccoli contain Vitamin K, which promotes clotting. This opposes the action of Warfarin. Patients should maintain a consistent, stable intake of these foods rather than avoiding them entirely to keep Warfarin levels steady.

• Tyramine and MAO Inhibitors ("Cheese Reaction"): Foods like aged cheese, cured meats, and fermented products are high in tyramine. MAO inhibitors block tyramine breakdown, leading to excessive catecholamine release and a dangerous rise in blood pressure.

• Smoking: Increases the activity of hepatic drug-metabolizing enzymes (CYP induction). This causes rapid metabolism and decreased effectiveness of drugs like Diazepam, Theophylline, Olanzapine, and Propoxyphene.

• Alcohol:

  • Chronic use: Induces hepatic enzymes, increasing metabolism and reducing levels of drugs like Warfarin and Phenytoin.

  • Acute use: Inhibits enzymes in non-alcoholic individuals, potentially leading to drug accumulation and toxicity.

  • Pharmacodynamic Interaction: Potentiates the effects of CNS depressants, leading to dangerous sedation and respiratory depression.

Adverse Drug Reactions (ADRs) and Management Strategies

• ADR Definition: A noxious and unintended response to a drug that occurs at doses normally used for prophylaxis, diagnosis, treatment, or the modification of physiological function.

• Management Strategies to Minimize Risks:

  • Dose Adjustment: Modifying the amount of drug based on known interactions.

  • Monitoring: Regularly checking blood levels or physiological markers (e.g., clotting time for Warfarin).

  • Patient Counseling: Instructing patients on food avoidance (e.g., the tyramine-cheese reaction) and the timing of medication (e.g., avoiding dairy with antibiotics).